
'Next Ozempic' aims to deliver 30% weight loss with fewer side effects
Fox News
A new experimental medication aims to improve upon Ozempic and other GLP-1 drugs by targeting four hormones simultaneously to minimize side effects.
"We built a single experimental peptide that works like four hormones at once, so we’re not pushing one button too hard." "There are plenty of highly effective GLP-1 agonists right in front of us." "The additional mechanisms offered by new drugs may help some, but not necessarily most weight-loss patients." Melissa Rudy is senior health editor and a member of the lifestyle team at Fox News Digital. Story tips can be sent to melissa.rudy@fox.com.
The goal is for the "quadruple-action" medication to achieve long-lasting weight loss of up to 30% — matching the effectiveness of bariatric surgery, which reduces the size of the stomach, according to a study press release.













